These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
77 related items for PubMed ID: 8302442
1. [Slow-release nicardipine in the treatment of arterial hypertension: comparative study vs. an ACE inhibitor]. De Cesaris R, Ranieri G, Bonfantino V, Adriani A, Filitti V, Ferrieri A. Minerva Cardioangiol; 1993 Oct; 41(10):457-63. PubMed ID: 8302442 [Abstract] [Full Text] [Related]
2. [Antihypertensive action of nicardipine retard in 24 hours and its effect on stress]. De Cesaris R, Ranieri G, Andriani A, Filitti V, Bonfantino MV, Lamontanara G, Ferrieri A. Minerva Med; 1993 Oct; 84(10):533-9. PubMed ID: 8247308 [Abstract] [Full Text] [Related]
3. [Efficacy and tolerability of nicardipine retard and captopril in hypertension in the aged. Results of a multicenter study]. Mancia G, Buoninconti R, Errico M, Freda M, Giordano MP, Granata Q, Lucentini ML, Marsili P, Pasotti C, Piccolo E. Minerva Med; 1992 Nov; 83(11):731-8. PubMed ID: 1461544 [Abstract] [Full Text] [Related]
5. [Effects of slow-release nicardipine on blood pressure, renal function and the renin-angiotensin-aldosterone system in patients with mild-to-moderate essential arterial hypertension]. Melina D, Guerrera G, Santoliquido A, Colivicchi F, Melina G, Musumeci V, Guerrera C. Clin Ter; 1992 Nov; 139(3-4):101-6. PubMed ID: 1837249 [Abstract] [Full Text] [Related]
7. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors. McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K, Sibutramine in Hypertensives Clinical Study Group. J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224 [Abstract] [Full Text] [Related]
9. Effects of efonidipine, nicardipine and captopril on proteinuria in aged spontaneously hypertensive rats. Shudo C, Masuda Y, Sugita H, Tamura T, Furukawa S, Hayashi K, Hirata H, Shikada K, Tanaka S, Tomita K. Arzneimittelforschung; 1996 Sep; 46(9):852-4. PubMed ID: 8876932 [Abstract] [Full Text] [Related]
10. Equivalent effects of nicardipine and captopril on urinary albumin excretion of type 2, non-insulin-dependent diabetic subjects with mild to moderate hypertension. Bouhanick B. Therapie; 1996 Sep; 51(1):41-7. PubMed ID: 8762219 [Abstract] [Full Text] [Related]
11. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study. Rosei EA, Rizzoni D, DIMS II (Delapril-Indapamide Multicenter Study II). J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793 [Abstract] [Full Text] [Related]
12. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA. J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [Abstract] [Full Text] [Related]
13. [A comparison of the effect of oral captopril and nicardipine in hypertensive crisis]. Addad F, Ferjani H, Chaabani A, Jelliti M, Gamra H, Makni H, Khaldoun BH, Dridi Z, Ben Farhat M. Tunis Med; 2008 Feb; 86(2):150-4. PubMed ID: 18444532 [Abstract] [Full Text] [Related]
15. [Effects of i.v. nicardipine in the treatment of hypertensive crisis]. Bolognesi R, Tsialtas D, Straneo U, Conti M, Manca C. Minerva Cardioangiol; 1990 Jun; 38(6):299-303. PubMed ID: 2250772 [Abstract] [Full Text] [Related]
16. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R. Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [Abstract] [Full Text] [Related]
17. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment]. Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL. Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399 [Abstract] [Full Text] [Related]
18. Long-acting nicardipine for elderly hypertensive patients: effect on diurnal variation of blood pressure. Harada T, Imamura T, Hara K, Sakai A, Fukui J, Kubo S, Fujiwara H, Shikuwa M, Tanioka Y, Yamasa T. Clin Ther; 1994 Aug; 16(3):386-93. PubMed ID: 7923305 [Abstract] [Full Text] [Related]
19. [Effects of the long-term treatment with losartan and captopril and of the abrupt cessation on circadian blood pressure profile]. Gorbunov VM, Savina LV, Metelitsa VI, Deev AD. Eksp Klin Farmakol; 2001 Aug; 64(2):45-50. PubMed ID: 11548448 [Abstract] [Full Text] [Related]
20. [The efficacy of nicardipine in treating arterial hypertension in elderly patients. A multicenter outpatient study]. Calvo Gómez C, Lado Lado FL, Cinos Ramos L, Pérez Leiros P, Justo Firvida E. An Med Interna; 1992 Apr; 9(4):170-4. PubMed ID: 1581451 [Abstract] [Full Text] [Related] Page: [Next] [New Search]